Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01519583 · ClinicalTrials.gov registry record · NA
WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT01519583 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 115 participants.
The verdict
NCT01519583, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.
Interventions
- BEHAVIORAL Control Group
- BEHAVIORAL Basic Intervention
- BEHAVIORAL Enhanced Pedometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01519583
The ClinicalTrials.gov registry entry for NCT01519583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Control Group is the first listed.
NCT01519583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01519583 about?
NCT01519583 is a clinical study titled "WalkMore Walking Interventions for Overweight/Obese Postmenopausal Women". The WalkMore study will help find out how walking interventions can help overweight/obese postmenopausal women with increased risk of cardiovascular disease lower their blood pressure.
What is the current status of trial NCT01519583?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2012-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01519583?
The interventions under investigation include: Control Group (BEHAVIORAL), Basic Intervention (BEHAVIORAL), Enhanced Pedometry (BEHAVIORAL).
Who is sponsoring clinical trial NCT01519583?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.